Showing results (31-40 of 250) with videos related to
Sort By:
Pageof 25
Vaccines|October 26, 2021
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and BeyondCharalampos Theocharopoulos, Panagiotis-Petros Lialios, Michael Samarkos, et al.Immunotherapy|July 7, 2016
IFN-λ cancer immunotherapy: new kid on the blockAhmed Lasfar, Helen Gogas, Andrew Zloza, et al.Journal for Immunotherapy of Cancer|September 6, 2019
Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendationsAmalia Anastasopoulou, Dimitrios C Ziogas, Michael Samarkos, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 20, 2020
Encephalitis in a Patient With Melanoma Treated With Immune Checkpoint Inhibitors: Case Presentation and Review of the LiteratureAikaterini Gkoufa, Helen Gogas, Panagiotis T Diamantopoulos, et al.Anticancer Research|June 1, 2018
Abdominal Emergencies in Patients with Stage IV Melanoma: The Role of Surgery: A Single-centre ExperienceDimitrios Mantas, Christos Damaskos, Nikolaos Garmpis, et al.Cancers|June 24, 2022
Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin CancersDimitrios C Ziogas, Anastasios Martinos, Dioni-Pinelopi Petsiou, et al.Frontiers in Oncology|August 12, 2022
Neoadjuvant treatment in ovarian cancer: New perspectives, new challengesAdamantia Nikolaidi, Elena Fountzilas, Florentia Fostira, et al.Melanoma Research|April 19, 2017
Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse eventsPanagiotis T Diamantopoulos, Maria Gaggadi, Eva Kassi, et al.European Journal of Epidemiology|October 23, 2012
Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) studyParaskevi Panagopoulou, Helen Gogas, Nick Dessypris, et al.Clinical Therapeutics|July 23, 2013
The role of adiponectin as a compensatory mediator for the primary secretory defect in latent autoimmune diabetes in adultsErifili Hatziagelaki, Vaia Lambadiari, Anastasia Tsiavou, et al.Pageof 25